Risk of HCC and Hepatic Decompensation in Individuals With Non-Alcoholic Fatty Liver Disease With and Without Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Gastroenterology & Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis
Lancet Gastroenterol Hepatol 2023 Jul 04;[EPub Ahead of Print], DQ Huang, N Noureddin, V Ajmera, M Amangurbanova, R Bettencourt, E Truong, T Gidener, H Siddiqi, AM Majzoub, T Nayfeh, N Tamaki, N Izumi, M Yoneda, A Nakajima, R Idilman, M Gumussoy, DK Oz, A Erden, AM Allen, M Noureddin, R LoombaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.